Multicenter phase II study of S-1 monotherapy as second-line chemotherapy for advanced biliary tract cancer refractory to gemcitabine-Reference-Cited by-同舟云学术

Multicenter phase II study of S-1 monotherapy as second-line chemotherapy for advanced biliary tract cancer refractory to gemcitabine

Published:2010-10-06 Issue:2 Volume:30 Page:708-713
ISSN:0167-6997
Container-title:Investigational New Drugs
language:en
Short-container-title:Invest New Drugs

Author:

Sasaki Takashi,Isayama Hiroyuki,Nakai Yousuke,Mizuno Suguru,Yamamoto Keisuke,Yagioka Hiroshi,Yashima Yoko,Kawakubo Kazumichi,Kogure Hirofumi,Togawa Osamu,Matsubara Saburo,Ito Yukiko,Sasahira Naoki,Hirano Kenji,Tsujino Takeshi,Toda Nobuo,Tada Minoru,Omata Masao,Koike Kazuhiko

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10637-010-9553-9.pdf

Reference20 articles.

1. National Cancer Center. Cancer statistics in Japan 2009. http://www.fpcr.or.jp/publication/statistics.html . Accessed 1 August, 2010.

2. Eckel F, Schmid RM (2007) Chemotherapy in advanced biliary tract carcinoma: a pooled analysis of clinical trials. Br J Cancer 96(6):896–902

3. Knox JJ, Hedley D, Oza A, Feld R, Siu LL, Chen E et al (2005) Combining gemcitabine and capecitabine in patients with advanced biliary cancer: a phase II trial. J Clin Oncol 23(10):2332–2338

4. Andre T, Reyes-Vidal JM, Fartoux L, Ross P, Leslie M, Rosmorduc O et al (2008) Gemcitabine and oxaliplatin in advanced biliary tract carcinoma: a phase II study. Br J Cancer 99(6):862–867

5. Sasaki T, Isayama H, Nakai Y, Ito Y, Kogure H, Togawa O et al (2010) Multicenter, phase II study of gemcitabine and S-1 combination chemotherapy in patients with advanced biliary tract cancer. Cancer Chemother Pharmacol 65(6):1101–1107

Cited by 76 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Trastuzumab Deruxtecan in Human Epidermal Growth Factor Receptor 2–Expressing Biliary Tract Cancer (HERB; NCCH1805): A Multicenter, Single-Arm, Phase II Trial;Journal of Clinical Oncology;2024-08-05

2. Clinical outcomes for previously treated patients with advanced biliary tract cancer: a meta-analysis;Future Oncology;2024-04

3. Перихілярна холангіокарцинома, або пухлина Клацкіна: погляд з точки зору японських рекомендацій;Practical oncology;2023-05-09

4. Favorable Management of Repeated Serous Retinal Detachment with Continued Tumor Response in a Patient with Intrahepatic Cholangiocarcinoma during Treatment with Pemigatinib;Internal Medicine;2023-04-15

5. Second line drug therapy for biliary cancer;Meditsinskiy sovet = Medical Council;2022-12-06